American College of Preventive Medicine Practice Policy Statement: perimenopausal and postmenopausal hormone replacement therapy

H Nawaz; D L Katz

doi:10.1016/s0749-3797(99)00072-0

American College of Preventive Medicine Practice Policy Statement: perimenopausal and postmenopausal hormone replacement therapy

Am J Prev Med. 1999 Oct;17(3):250-4. doi: 10.1016/s0749-3797(99)00072-0.

Authors

H Nawaz¹, D L Katz

Affiliation

¹ Yale-Griffin Prevention Research Center and Department of Preventive Medicine, Griffin Hospital, Yale University School of Medicine, Derby, Connecticut 06408, USA. haqnawaz@pol.net

PMID: 10987643
DOI: 10.1016/s0749-3797(99)00072-0

Abstract

Based on a review of current literature and recommendations, the American College of Preventive Medicine presents a practice policy statement on perimenopausal hormone replacement therapy.

Publication types

Guideline
Practice Guideline

MeSH terms

Breast Neoplasms / etiology
Cardiovascular Diseases / prevention & control
Endometrial Neoplasms / etiology
Estrogen Replacement Therapy* / adverse effects
Female
Health Policy
Humans
Osteoporosis, Postmenopausal / prevention & control
United States